MANH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Manhattan Associates Inc (MANH) is not a strong buy at the moment for a beginner, long-term investor. While the company has demonstrated consistent financial growth and maintains a strong technical moat, the lack of significant positive trading signals, neutral insider and hedge fund activity, and recent negative news sentiment suggest a cautious approach. Additionally, with the stock trading near a key pivot point and no strong upward momentum, it is better to wait for clearer entry signals or more favorable conditions.
The MACD is positive and expanding, indicating mild bullish momentum. However, the RSI is neutral at 51.644, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot point of 129.459, with resistance at 137.336 and support at 121.582. Overall, the technical indicators suggest a lack of strong momentum in either direction.
The company's financial performance in Q4 2025 showed revenue growth of 5.70% YoY, net income growth of 8.20% YoY, and EPS growth of 11.69% YoY. Analysts highlight the company's strong technical moat and potential for monetizing its domain expertise in warehouse management.
Rosen Law Firm's investigation into potential fiduciary breaches could weigh on investor sentiment. Additionally, the gross margin dropped by 1.41% YoY, and the stock's valuation is under pressure due to concerns about AI disruption in the supply chain software sector. Analyst price targets have been revised downward recently.
In Q4 2025, Manhattan Associates reported revenue of $270.39M (up 5.70% YoY), net income of $51.95M (up 8.20% YoY), and EPS of $0.86 (up 11.69% YoY). However, gross margin dropped to 54.41% (down 1.41% YoY).
Analysts have mixed views. Rothschild & Co Redburn lowered the price target to $145 from $160 and maintained a Neutral rating, citing low valuations due to AI disruption concerns but acknowledged the company's strong technical moat. Barclays lowered the price target slightly to $236 from $237 but maintained an Overweight rating, citing a short-cycle recovery in the industrial technology sector. DA Davidson lowered the price target to $240 from $250 but maintained a Buy rating, highlighting strong Q4 results and potential revenue reacceleration.
